SCHEMBL25499141

SCHEMBL25499141

CC(=O)C1CCN(C(=O)C2CCN(C)CC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.55
LMNA P02545 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
TSHR P16473 2/20 0.47
CHRNB2 P17787 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
CHRNB3 Q05901 1/20 0.44
CHRNA6 Q15825 1/20 0.44
SMYD3 Q9H7B4 1/20 0.43
RECQL P46063 1/20 0.41
HSD11B1 P28845 1/20 0.41
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12436922 0.90 HPGD (0.58) HTTLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL25512069 0.89 LMNA (0.50) HTTLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL25498167 0.89 LMNA (0.50) HTTLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL25511897 0.89 NAMPT (0.45) HTTLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL25498361 0.89 NAMPT (0.45) HTTLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL25512218 0.89 NAMPT (0.45) HTTLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL25498347 0.88 HTT (0.70) HTTLMNAALDH1A1HPGDTSHR
SCHEMBL25498169 0.88 HTT (0.70) HTTLMNAALDH1A1HPGDTSHR
SCHEMBL890089 0.87 CYP1A2 (0.44) HTTLMNASMN1; SMN2ALDH1A1KMT2A
SCHEMBL25499234 0.86 LMNA (0.51) HTTLMNASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086399-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF NURIX THERAPEUTICS, INC. (US) 2023-05-19 WO disclosed